DCM
IDXX icon

DGS Capital Management’s Idexx Laboratories IDXX Stock Holding History

DGS Capital Management’s Portfolio IDXX Stock Details IDXX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$1.12M Sell
2,000
-100
-5% -$64.1K 0.18% 105
2025
Q4 		$1.42M Hold
2,100
– – 0.24% 75
2025
Q3 		$1.34M Buy
+2,100
New +$1.27M 0.24% 73

Other funds holding IDXX

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
BAMCO Inc
BAMCO Inc New York $33.1B AUM 11.16% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Fundsmith LLP
Fundsmith LLP London, United Kingdom $12.8B AUM 6.9% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

DGS Capital Management's IDXX Position: Q1 2026 in Review

DGS Capital Management reduced its Idexx Laboratories (IDXX) stake by 11% in Q1 2026, selling an estimated $283K and leaving 3,750 shares worth $2.11M. The position accounts for 0.35% of the portfolio, ranked #51.

DGS Capital Management first reported a position in IDXX in Q4 2021 and has held it in 18 quarters since. The position peaked at $2.84M in Q4 2025. 1,311 funds tracked by Wall St. Rank hold IDXX as of Q1 2026.

  • DGS Capital Management held 3,750 shares of Idexx Laboratories worth $2.11M as of Q1 2026.
  • DGS Capital Management sold 442 Idexx Laboratories shares in Q1 2026, an estimated $283K.
  • Idexx Laboratories made up 0.35% of DGS Capital Management's portfolio in Q1 2026, its #51 holding.
  • DGS Capital Management first reported a position in Idexx Laboratories in Q4 2021 and has held it in 18 quarters since.
  • DGS Capital Management's Idexx Laboratories position peaked at $2.84M in Q4 2025.
  • 1,311 funds tracked by Wall St. Rank held Idexx Laboratories as of Q1 2026.

Based on DGS Capital Management's 13F filing for Q1 2026, filed 28 Apr 2026.